Animal-Free Lung Model Advances RSV Treatment for Infants
New research from University College London (UCL) and Great Ormond Street Hospital (GOSH) indicates that effective respiratory syncytial virus (RSV) treatments for infants must target both the virus and the host’s immune response. Published in Nature Communications, the study utilized a novel lab-grown model of infant airways to demonstrate that the pediatric immune system triggers … Read more